STRENGTHS AND LIMITATIONS OF THIS STUDY
DIABETIC MACULAR OEDEMA
Study is based on a high-quality randomised clinical trial.First study to compare the cost-effectiveness of subthreshold micropulse laser with that of standard laser for the treatment of diabetic macular oedema.The analysis was from a UK National Health Service (NHS) and personal social services perspective and did not consider costs such as productivity losses from a societal perspective.Low rate of missing data for both costs and outcomes.We used published costs of anti-vascular endothelial growth factor drugs, rather than NHS costs which incorporates confidential price discounts for these drugs.